The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.
request for cryopreserved ovarian tissue transplantation;
premature ovarian failure or irregular mentrual cycles;
negative test for HIV, HBV, HCV, Treponema pallidum;
negative PAP test;
neoplastic contamination in cryopreserved ovarian tissue;
history of endometriosis;
endocrinological disorders present and not treated (uncompensated thyroid dysfunction, diabetes (type 1, type 2);
body mass index (BMI) >30 kg/m2;